BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goyert N, Eeson G, Kagedan DJ, Behman R, Lemke M, Hallet J, Mittmann N, Law C, Karanicolas PJ, Coburn NG. Pasireotide for the Prevention of Pancreatic Fistula Following Pancreaticoduodenectomy: A Cost-effectiveness Analysis. Ann Surg. 2017;265:2-10. [PMID: 27537539 DOI: 10.1097/sla.0000000000001889] [Cited by in Crossref: 23] [Cited by in F6Publishing: 5] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Yuan F, Gafni A, Gu C, Serrano PE. Does giving pasireotide to patients undergoing pancreaticoduodenectomy always pay for itself? Eur Surg 2020;52:132-40. [DOI: 10.1007/s10353-018-0563-8] [Reference Citation Analysis]
2 Kawaida H, Kono H, Hosomura N, Amemiya H, Itakura J, Fujii H, Ichikawa D. Surgical techniques and postoperative management to prevent postoperative pancreatic fistula after pancreatic surgery. World J Gastroenterol 2019; 25(28): 3722-3737 [PMID: 31391768 DOI: 10.3748/wjg.v25.i28.3722] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 23] [Article Influence: 9.7] [Reference Citation Analysis]
3 Sugimoto M, Takahashi S, Kojima M, Kobayashi T, Gotohda N, Konishi M. In Patients with a Soft Pancreas, a Thick Parenchyma, a Small Duct, and Fatty Infiltration Are Significant Risks for Pancreatic Fistula After Pancreaticoduodenectomy. J Gastrointest Surg 2017;21:846-54. [PMID: 28101719 DOI: 10.1007/s11605-017-3356-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 6.4] [Reference Citation Analysis]
4 Nakamura K, Sho M, Kinoshita S, Akahori T, Nagai M, Nakagawa K, Takagi T, Ikeda N. New insight into the association between bile infection and clinically relevant pancreatic fistula in patients undergoing pancreatoduodenectomy. J Hepatobiliary Pancreat Sci 2020;27:992-1001. [PMID: 32506812 DOI: 10.1002/jhbp.781] [Reference Citation Analysis]
5 Ellis RJ, Brock Hewitt D, Liu JB, Cohen ME, Merkow RP, Bentrem DJ, Bilimoria KY, Yang AD. Preoperative risk evaluation for pancreatic fistula after pancreaticoduodenectomy. J Surg Oncol 2019;119:1128-34. [PMID: 30951614 DOI: 10.1002/jso.25464] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
6 Newton AD, Newhook TE, Bruno ML, Prakash L, Chiang YJ, Arango NP, Dewhurst WL, Arvide EM, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CD. Iterative Changes in Risk-Stratified Pancreatectomy Clinical Pathways and Accelerated Discharge After Pancreaticoduodenectomy. J Gastrointest Surg 2022. [PMID: 35023033 DOI: 10.1007/s11605-021-05235-3] [Reference Citation Analysis]
7 Wang H, Jin J, Zhu F, Peng F, Wang M, Qin R. The ratio of abdominal depth to body mass index is a preoperative predictor of postoperative complications after laparoscopic pancreaticoduodenectomy: a retrospective propensity score matched analysis. Surg Endosc 2021;35:6472-80. [PMID: 33156385 DOI: 10.1007/s00464-020-08140-z] [Reference Citation Analysis]
8 Tarvainen T, Sirén J, Kokkola A, Sallinen V. Effect of Hydrocortisone vs Pasireotide on Pancreatic Surgery Complications in Patients With High Risk of Pancreatic Fistula: A Randomized Clinical Trial. JAMA Surg 2020;155:291-8. [PMID: 32022887 DOI: 10.1001/jamasurg.2019.6019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
9 Kunstman JW, Goldman DA, Gönen M, Balachandran VP, D'Angelica MI, Kingham TP, Jarnagin WR, Allen PJ. Outcomes after Pancreatectomy with Routine Pasireotide Use. J Am Coll Surg 2019;228:161-170.e2. [PMID: 30414453 DOI: 10.1016/j.jamcollsurg.2018.10.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
10 Peng JS, Joyce D, Brady M, Groman A, Attwood K, Kuvshinoff B, Hochwald SN, Kukar M. Risk-stratified analysis of pasireotide for patients undergoing pancreatectomy. J Surg Oncol 2020;122:195-203. [PMID: 32474957 DOI: 10.1002/jso.25949] [Reference Citation Analysis]